drug · small molecule
minoxidil ER
Phase 3updated 5mo agoby $MANE Veradermics, Inc🔗 ChEMBL
Phase 3community read0 votes
🐶 often sniffed alongside
top 4Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for hypertension and hypotrichosis and 5 investigational indications.
targets
Sulfonylurea receptor 2, Kir6.2
all catalysts(0)
nothing on the calendar yet
Trials studying minoxidil ER
- phase3Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
- N/AEffects of a Topical Serum Solution on Hair Characteristics
- phase3Efficacy & Safety of Minoxidil SL Tablets in Men With AGA
- phase3Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.
- phase3Androgenic Alopecia TH07 Clinical Trial
- phase3Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia
- phase2Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia
- phase3Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia
News(6)
- Veradermics keeps ‘momentum going’ as baldness drug helps women with hair lossThe Phase 2 data exceeded expectations, lifting company shares as high as nearly $130 apiece and building the case for what may be the first pill specifically approved for female pattern hair loss.biopharma_dive · 2mo ago
- STAT+: Celcuity’s breast cancer drug approved, its firstFDA's new CBER chief promises normalcy, an weight loss drug without GLP-1s, and more biotech news from The Readoutstat · 2mo ago
- Veradermics declares first efficacy win in women for hair loss drugVeradermics is for the first time reporting positive efficacy of its oral formulation of minoxidil in female pattern hair loss, which broadens the market potential of its flagship asset. In a mid-s…endpoints · 2mo ago
- Veradermics soars on positive data for baldness treatmentThe results could support the first approval in decades for an oral medicine that can treat male pattern baldness, though the therapy will face competition from generics and over-the-counter medica…biopharma_dive · 5mo ago
- STAT+: Astellas retries XLMTM gene therapy after deathsVeradermics' hair loss pill late-stage trial success, FDA fast-tracks reviews for psychedelics, and more biotech newsstat · 5mo ago
- Veradermics wins at growing hair with oral Rogaine in first key test as a public companyVeradermics has succeeded in its first major test as a newly-minted public company. The biotech's form of oral Rogaine cleared the bar in a Phase 2/3 trial in men with mild-to-moderate pattern hair…endpoints · 5mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that